Biology subjects

Horvat, B.

Publications and source records attributed to Horvat, B..

6 recordsLinked to original sources

bioRxiv2026

Noncanonical P gene mRNA editing in Cedar virus generates a V-like protein that is required for efficient virion production

Highly pathogenic Hendra and Nipah viruses encode accessory P gene products (C, V and W) that antagonize innate immunity and contribute to pathogenicity. Cedar virus (CedV), an apathogenic bat-borne henipavirus, is presumed to lack P gene mRNA editing and therefore is unable to express V and W proteins. Here, we identify CedV peptides originating from a frameshifted P gene open reading frame and demonstrate a previously unrecognized, noncanonical editing site at a homopolymeric adenine tract that introduces single-nucleotide A or G insertion. This mRNA editing produces a protein that we refer to as U protein, whose C-terminal domain shares sequence and predicted structural features with those of the henipavirus V protein. Recombinant CedV mutants defective in mRNA editing were only recoverable by trans-complementation and showed markedly reduced release of infectious virus in cell culture and attenuated replication in mice lacking type I interferon receptor. Our data revise the CedV gene expression models and reveal a noncanonical editing mechanism that supports the production of a U protein critical for efficient infectious virus release. These results expand the fundamental concepts of paramyxovirus gene expression and reveal an unexpected requirement for P-gene editing in efficient infectious-virus production, with implications for the evaluation of potentially high-consequence paramyxoviruses.

microbiology↗

bioRxiv2025

Nipah virus Malaysia and Bangladesh strain-induced pathogenesis in mice lacking type I interferon receptor signaling

Nipah virus (NiV) is a zoonotic highly pathogenic Paramyxovirus inducing lethal outbreaks of encephalitis and severe acute respiratory syndrome (SARS) with an average case-fatality rate of 75%. Two viral strains, NiV-Malaysia (NiV-Mal) and NiV-Bangladesh (NiV-Ban), associated to distinct geographical distribution, route of transmission, symptoms and lethality have been described. Due to the permanent threat of these emerging infections and the lack of approved therapeutics, it is crucial to improve our understanding regarding NiV-associated pathogenesis. Mice represent a small and accessible animal model, provided with numerous biological tools for the functional assessment of different genes related to antiviral response. Here, we analyze the susceptibility of mice deficient for type I interferon receptor (IFNAR KO) to infection with either NiV-Mal or NiV-Ban through intraperitoneal or intranasal routes. Our results show that IFNAR KO mice are susceptible to NiV-Ban infection via intraperitoneal route, although to a lesser extent than NiV-Mal, and develop encephalitis and pulmonary syndrome with viral propagation to different organs and lethal outcome in 60% of infected animals. In addition, intranasal administration of both viral strains led to a subclinical infection with viral replication in brain and lungs and production of virus-specific neutralizing antibodies. These results indicate IFNAR KO mice as a small animal model permitting comparative studies of the immunopathogenesis perpetrated by both NiV-Mal and NiV-Ban infections. Author summaryAvailability of small animal models represents a major issue to characterize virus-associated pathogenesis to further implement therapeutic strategies. Previous studies performed with NiV-Mal and NiV-Ban strains in wild-type (WT) mice did not indicate signs of NiV disease. However, when challenged with NiV-Mal, IFNAR KO mice suffered fatal outcomes, thus providing useful information on viral immunopathogenesis. Surprisingly, while being the more frequently re-emerging virus strain, no infection studies with NiV-Ban have been performed in IFNAR KO mice so far. Here, we sought comparing pathogenesis after NiV-Mal- and NiV-Ban-infection following IP and IN inoculations in IFNAR KO mice. Indeed, our results highlighted that contrary to fatal IP challenge, IN inoculation lead to a subclinical infection with both NiV strains. Moreover, we determined that NiV-Mal is more pathogenic than NiV-Ban following IP infection. Finally, distinct histopathological manifestations and tropism were associated with each viral strain and specific route of infection. Overall, our study implies that IFNAR KO mice represent a useful animal model to study strain-specific NiV pathophysiology.

microbiology↗

bioRxiv2025

Structural and Mechanistic Basis for Antibody Neutralization of the Measles Fusion Protein

Measles virus (MeV) is a highly contagious viral pathogen and remains a major global health threat. Resurgent infections, driven by insufficient vaccine coverage, waning herd immunity, and the vulnerability of immunocompromised individuals, highlight the urgent need for effective countermeasures. Monoclonal antibodies (mAbs) represent a promising strategy, both as antiviral agents and as probes of viral entry mechanisms. While most vaccine-elicited neutralizing antibodies target the hemagglutinin (H) protein, emerging evidence suggests that antibodies against the fusion (F) protein are also potent inhibitors. Still, there is insufficient information on the target sites and activities of antibodies against the F protein. Like other class I fusion proteins, MeV F exists in a metastable prefusion state that undergoes dramatic conformational changes during viral entry. Here, we selected four mAbs that recognize conformational patterns of F-prefusion and/or postfusion, characterized their epitopes, specificities, and antiviral activities. Structural analyses mapped antibody interactions onto pre- and postfusion F conformations, revealing that all three neutralizing mAbs are specific for the prefusion form, while the non-neutralizing mAb recognizes only the postfusion F. Biophysical and functional assays defined distinct mechanisms: neutralization occurs either by stabilizing the prefusion protein or by preventing the extended intermediate from completing fusion. We also describe a novel mechanism of neutralization in which an antibody prematurely triggers F activation but blocks the subsequent refolding required for viral entry. Together, these findings provide the first detailed mapping of neutralizing epitopes on the MeV F protein and establish a framework for the rational design of F-targeted intervention.

immunology↗

bioRxiv2025

Differential Immunomodulatory Properties of Langya and Nipah Virus Proteins

Langya virus (LayV) is a shrew-borne emerging parahenipavirus first identified in 2018 in 35 febrile patients in China. The closely related Nipah virus (NiV) is a highly pathogenic emerging bat-borne henipavirus that has caused numerous outbreaks with public health concerns in Asia. Among other symptoms, NiV causes severe acute respiratory syndrome and encephalitis, leading to high lethality. Thus, although closely related, infections with these two emerging and zoonotic viruses have distinct pathogenicity. Since the interplay with the hosts immune system is a key determinant of species barrier crossing and pathogenicity, we aimed at deciphering the ability of LayV to counteract the human intrinsic immunity using the better-characterised NiV as a prototype. NiV expresses the P, V, and W proteins, known to hinder the hosts innate immune response during infection. We thus compared the immunomodulatory properties of LayV and NiV proteins in human cells and showed that, similarly to NiV, the C-terminal domain of LayV V proteins inhibits the response to the activation of the pattern recognition receptor MDA5. However, although the N-terminal region of LayV P can inhibit the interferon signalling, it is not as efficient as its NiV counterpart. Moreover, only NiV W inhibits MDA5 and RIG-I signalling pathways. Similarly, unlike NiV, LayV W cannot efficiently block the activation of the NF-{kappa}B promoter after stimulation with IL-1{beta}. These results suggest that LayV is less efficient than NiV in counteracting the human intrinsic immunity, which may contribute to the difference in severity observed between NiV and LayV-infected patients. IMPORTANCELangya virus (LayV) is a shrew-borne emerging parahenipavirus recently identified in patients in China with symptoms such as fever, fatigue, cough, anorexia, headache, and vomiting. Since the interaction between a virus and its hosts immune system is an essential parameter influencing host adaptation and disease severity, we investigated the interplay between LayV and the human intrinsic immunity using as a prototype the better-characterized and closely related Nipah virus (NiV), a highly pathogenic henipavirus. We compared the immunomodulatory properties of LayV and NiV proteins in human cells and showed that, similarly to NiV, some of LayV proteins can inhibit human signalling pathways, while, unlike NiV, LayV W protein is unable to block essential immune pathways. This suggests that LayV is less efficient than NiV in counteracting the human intrinsic immunity, which may contribute to the difference in severity between NiV and LayV-infected patients.

microbiology↗

bioRxiv2020

Activation of cGAS/STING pathway upon paramyxovirus infection

During inflammatory diseases, cancer and infection, the cGAS/STING pathway is known to recognize foreign or self-DNA in the cytosol and activate an innate immune response. Here, we report that negative-strand RNA paramyxoviruses, Nipah virus (NiV) and Measles virus (MeV), can also trigger the cGAS/STING axis. While mice deficient for MyD88, TRIF and MAVS still moderately control NiV infection when compared to WT mice, additional STING deficiency resulted in 100% lethality, suggesting synergistic roles of these pathways in host protection. Moreover, deletion of cGAS or STING resulted in decreased type-I interferon production with enhanced paramyxoviral infection in both human and murine cells. Finally, the phosphorylation and ubiquitination of STING, observed during viral infections, confirmed the activation of cGAS/STING pathway by NiV and MeV. Our data suggest that cGAS/STING activation is critical in controlling paramyxovirus infection, and possibly represent attractive targets to develop countermeasures against severe disease induced by these pathogens.

immunology↗

bioRxiv2019

Reprogrammed Pteropus Bat Stem Cells Present Distinct Immune Signature And Are Highly Permissive For Henipaviruses

Bats are unique among mammals due to the ability of powered flight and exceptional longevity. They are also asymptomatic hosts for numerous viruses, including recently emerged zoonotic Henipaviruses Nipah and Hendra, which are highly pathogenic for humans and other mammals. Better understanding of how bats control viral infection requires development of relevant permissive cellular experimental models. By applying a somatic reprogramming protocol to Pteropus bat primary cells, using a novel combination of ESRRB, CDX2, and c-MYC transcription factors, we generated bat reprogrammed cells exhibiting stem cell-like characteristics and a neural stem cell-like molecular signature. These cells present a unique interferon-stimulated transcriptomic signature and both produce and respond to interferon type-I, highlighting differences between stem cells from bats and other mammals. In contrast to primary bat cells, these reprogrammed cells are highly susceptible to infection by Henipavirus, thereby enabling isolation of new bat viruses, study of virus-bat interactions, and better understanding of bat biology. Summary sentenceSomatic reprogramming provides new bat stem cells with unique immune properties and original viral permissivness

cell biology↗